Your topics. New publications.

A compact browser notification when there’s something new. At most once a day — no account needed.

What interests you?

Optional and switchable off here at any time. We save your selected topics and device subscription; no email address is required. Privacy

Search the harborEN/DEAccount
Hallmarks of aging
Research brief

Alpha-klotho and insulin resistance in older adults: a cohort analysis

In an abstract of a cohort of 825 adults aged 55 and older, higher alpha-klotho measured 3 years after enrollment was associated with higher insulin resistance among overweight participants, but not with incident diabetes. [1]

Automatic summary · not editorially reviewed

The key findings

  1. The abstract aimed to examine alpha-klotho's association with insulin resistance and incident diabetes in older adults and whether it differs by body mass index. [1]

  2. Among 370 overweight participants, each logarithm unit of alpha-klotho was associated with 0.51 higher HOMA-IR after adjustment. [1]

  3. Alpha-klotho was not significantly associated with incident diabetes overall or in any BMI subgroup. [1]

The source at a glance

Study type / format
Secondary analysis of a prospective population-based cohort (abstract).
Population / context
825 community-dwelling adults aged 55 or older in the Invecchiare in Chianti Study.
Summary based on
Study abstract
Original publication
June 24, 2026

Alpha-klotho and metabolic outcomes in older adults

The abstract describes alpha-klotho as a circulating protein linked to better metabolic and aging-related outcomes, but says its relationship with insulin resistance and the role of body fat remain unclear, especially in older adults. The stated aim was to examine the association of circulating alpha-klotho with insulin resistance measures and incident diabetes in older adults, and whether this differs by body mass index.

Supporting source [1]

Overweight subgroup showed higher HOMA-IR

This secondary analysis used 825 community-dwelling adults aged 55 or older from the Invecchiare in Chianti Study, a prospective population-based cohort. Alpha-klotho and outcomes were assessed 3 years after enrollment. Among 370 overweight participants (BMI 25.0–29.9), each logarithm unit of alpha-klotho was associated with 0.51 higher HOMA-IR (95% CI 0.07–0.94) after adjustment, and with higher serum glucose (Beta 0.56, 95% CI 0.04–1.09), but not serum insulin. No significant associations appeared in the other BMI groups (interaction P = 0.18).

Supporting source [1]

No link to incident diabetes in any BMI group

Alpha-klotho was not significantly associated with incident diabetes, overall or in any BMI subgroup. The authors conclude that alpha-klotho was positively associated with insulin resistance, but not incident diabetes, among overweight adults, and suggest a context-dependent relationship. These are associations from an observational cohort, not evidence of cause; the abstract does not report effect sizes for the diabetes outcome or the number of diabetes cases.

Supporting source [1]

How to interpret this

Abstract only; the full text was not reviewed. This is a secondary analysis of one observational cohort, so associations are not causal. The abstract does not report diabetes case counts or effect sizes for that outcome, and the interaction test was not significant.

Based on the study abstract; the full paper, tables and supplementary data were not reviewed.

Source & supporting passages

[1]
Alpha-klotho, insulin resistance, and adiposity among older adults.

Ahmad A, Shardell M, Kalyani RR, Semba RD, Mitchell BD, Tanaka T, Taylor S, Shrestha A, Ferrucci L. · europepmc.org · June 24, 2026

Read the quoted passagesIn the language of the original source
  1. Finding 1 ↑

    examine whether these relationships differ by body
  2. Finding 2 ↑

    0.51 higher HOMA-IR (95% confidence interval
  3. Finding 3 ↑

    not significantly associated with incident diabetes

AI-assisted summary with linked source passages. No independent editorial or clinical review.

Our editorial method

Discussion

Community discussions

0 topics

Member contributions. Share sources, disclose commercial interests, and avoid personal medical or dosing advice.

Loading…